🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of Tylenol, alleging the firms hid potential risks that the pain reliever created to pediatric neurological development.

The court filing comes four weeks after President Donald Trump publicized an unsubstantiated connection between taking acetaminophen - referred to as acetaminophen - during pregnancy and autism spectrum disorder in children.

Paxton is suing the pharmaceutical giant, which formerly manufactured the drug, the sole analgesic approved for pregnant women, and the current manufacturer, which currently produces it.

In a official comment, he stated they "misled consumers by profiting off of pain and promoting medication ignoring the potential hazards."

Kenvue says there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These manufacturers lied for decades, deliberately risking millions to line their pockets," Paxton, from the Republican party, declared.

The manufacturer stated officially that it was "deeply concerned by the spread of false claims on the safety of paracetamol and the likely effects that could have on the welfare of American women and children."

On its official site, the company also stated it had "regularly reviewed the relevant science and there is insufficient valid information that demonstrates a verified association between using paracetamol and autism."

Organizations representing doctors and health professionals agree.

The leading OB-GYN organization has said paracetamol - the primary component in Tylenol - is a restricted selection for expectant mothers to treat discomfort and fever, which can create significant medical dangers if not addressed.

"In over twenty years of investigation on the use of acetaminophen in pregnancy, not a single reputable study has conclusively proven that the consumption of acetaminophen in any stage of pregnancy leads to neurological conditions in children," the association commented.

The lawsuit cites current declarations from the previous government in arguing the drug is reportedly hazardous.

In recent weeks, Trump raised alarms from public health officials when he advised expectant mothers to "struggle intensely" not to take acetaminophen when ill.

The US Food and Drug Administration then issued a notice that medical professionals should think about restricting the consumption of Tylenol, while also stating that "a causal relationship" between the drug and autism in young ones has not been established.

Health Secretary Robert F Kennedy Jr, who supervises the FDA, had promised in April to undertake "a massive testing and research effort" that would establish the source of autism spectrum disorder in a matter of months.

But experts warned that identifying a unique factor of autism spectrum disorder - considered by experts to be the outcome of a complicated interplay of inherited and environmental factors - would be difficult.

Autism is a type of enduring cognitive variation and condition that impacts how people encounter and engage with the world, and is diagnosed using medical professional evaluations.

In his legal document, Paxton - a Trump ally who is seeking US Senate - alleges Kenvue and J&J "deliberately disregarded and attempted to silence the research" around paracetamol and autism spectrum disorder.

This legal action attempts to require the companies "remove any marketing or advertising" that states Tylenol is reliable for women during pregnancy.

The court case echoes the grievances of a assembly of mothers and fathers of young ones with autism and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in 2022.

The court dismissed the case, declaring investigations from the family's specialists was inconclusive.